Holen Sie sich die Stockscreener-App
16.40
1.17%
0.19
Handel nachbörslich:
16.39
-0.010
-0.06%
Roivant Sciences Ltd Aktie (ROIV) Neueste Nachrichten
Roivant Sciences president Venker sells $2m in shares - Investing.com India
Positive Phase 3 Data and Analyst Support Could Be a Game Changer for Roivant Sciences (ROIV) - simplywall.st
A Look at Roivant Sciences’s Valuation Following Positive Phase 3 Result for Brepocitinib - Sahm
Roivant Sciences Ltd. stock prediction for this weekTrade Risk Report & AI Enhanced Trade Execution Alerts - newser.com
Using Ichimoku Cloud for Roivant Sciences Ltd. technicalsPortfolio Risk Summary & Technical Entry and Exit Alerts - newser.com
Top chart patterns to watch in Roivant Sciences Ltd.Trade Performance Summary & Community Verified Watchlist Alerts - newser.com
Evaluating Roivant Sciences Ltd. with trendline analysisQuarterly Portfolio Review & Fast Gaining Stock Reports - newser.com
Key metrics from Roivant Sciences Ltd.’s quarterly dataQuarterly Portfolio Review & Fast Gaining Stock Reports - newser.com
What MACD and RSI say about Roivant Sciences Ltd.Trade Entry Summary & Weekly Watchlist of Top Performers - newser.com
Roivant Sciences Ltd. (ROIV) Stock Analysis: An Attractive 24.97% Upside in the Biotech Arena - DirectorsTalk Interviews
How sentiment analysis helps forecast Roivant Sciences Ltd.Market Trend Report & Fast Moving Stock Trade Plans - newser.com
Using Bollinger Bands to evaluate Roivant Sciences Ltd.July 2025 Trends & Community Consensus Picks - newser.com
Is a relief rally coming for Roivant Sciences Ltd. holders2025 Bull vs Bear & Daily Oversold Bounce Ideas - newser.com
Combining machine learning predictions for Roivant Sciences Ltd.July 2025 Decliners & Reliable Volume Spike Trade Alerts - newser.com
Price action breakdown for Roivant Sciences Ltd.2025 Market Overview & Precise Swing Trade Entry Alerts - newser.com
Will earnings trigger a reversal in Roivant Sciences Ltd.Weekly Market Summary & Safe Entry Zone Identification - newser.com
Eric Venker Sells 355,161 Shares of Roivant Sciences (NASDAQ:ROIV) Stock - MarketBeat
Eric Venker Sells 171,396 Shares of Roivant Sciences (NASDAQ:ROIV) Stock - MarketBeat
Eric Venker Sells 138,602 Shares of Roivant Sciences (NASDAQ:ROIV) Stock - MarketBeat
What earnings revisions data tells us about Roivant Sciences Ltd.Bear Alert & Comprehensive Market Scan Reports - newser.com
Is Roivant Sciences Ltd. (87S) stock undervalued historicallyPortfolio Risk Report & Real-Time Stock Entry Alerts - newser.com
Weiss Ratings Reaffirms "Sell (D+)" Rating for Roivant Sciences (NASDAQ:ROIV) - MarketBeat
Can Roivant Sciences Ltd. stock deliver consistent earnings growthPortfolio Value Report & Growth Focused Entry Reports - newser.com
Roivant Sciences Hits New 52-Week High at $16.19, Up 52.84% - Markets Mojo
Roivant Sciences Hits New 52-Week High at $16.79, Surges 53.69% - Markets Mojo
Roivant Sciences’ president Venker sells $10.7m in shares - Investing.com
Valeo Financial Advisors LLC Buys Shares of 101,576 Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant Sciences Rises on Nasdaq Composite with Strong Momentum - Kalkine Media
Roivant Sciences (NASDAQ:ROIV) Sets New 12-Month HighShould You Buy? - MarketBeat
Can you recover from losses in Roivant Sciences Ltd.2025 Price Action Summary & High Return Trade Guides - newser.com
What sentiment indicators say about Roivant Sciences Ltd. stockWeekly Trading Summary & Community Driven Trade Alerts - newser.com
Will Roivant Sciences Ltd. (87S) stock outperform value peersRisk Management & Consistent Profit Alerts - newser.com
Why Roivant Sciences (ROIV) Is Up 6.6% After Positive Phase 3 Brepocitinib Results and SEC Filing - simplywall.st
Why Roivant Sciences Ltd. (87S) stock attracts wealthy investorsTrade Risk Report & Fast Entry High Yield Stock Tips - newser.com
Will Roivant Sciences Ltd. continue its uptrendWeekly Investment Summary & Safe Capital Growth Tips - newser.com
Pattern recognition hints at Roivant Sciences Ltd. upsideMarket Growth Report & Safe Capital Growth Tips - newser.com
Why retail investors pile into Roivant Sciences Ltd. stock2025 Winners & Losers & Safe Entry Momentum Tips - newser.com
Is Roivant Sciences Ltd. stock reversal real or fakeM&A Rumor & High Win Rate Trade Tips - newser.com
Can Roivant Sciences Ltd. (87S) stock double in coming yearsJuly 2025 Breakouts & Fast Entry Momentum Alerts - newser.com
Roivant’s Brepocitinib Phase 3 Dermatomyositis Trial Hits Primary and All Key Secondary Endpoints - Insider Monkey
Why Analysts Are Rethinking Roivant Sciences After Strong Phase 3 Results and Analyst Upgrades - Yahoo Finance
Elevate Capital Advisors LLC Sells 61,368 Shares of Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant Sciences (ROIV) files mixed shelf - StreetInsider
Roivant Sciences (ROIV): Assessing Valuation Following Positive Phase 3 Results and Analyst Optimism - simplywall.st
Roivant Sciences Ltd. $ROIV Shares Purchased by GAMMA Investing LLC - Defense World
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):